Weight Loss Injections – NHS Eligibility Criteria

From 23 June 2025, following approval by NICE, Tirzepatide (Mounjaro®) will be available in the NHS for eligible patients who meet the strict, nationally-set, criteria.

To help patients avoid unnecessary appointments and disappointment, please read the information below before requesting an appointment to discuss Tirzepatide (Mounjaro®).

The current criteria is that patients are those with a BMI of 40 or higher, and with four or more of the qualifying comorbidities will be eligible for assessment to identify their suitability for Tirzepatide (Mounjaro®). Anyone not meeting these criteria will not be eligible for assessment in the first year of the drug being available.

To qualify for Tirzepatide (Mounjaro®) on the NHS, you must meet all the following criteria:

1. BMI over 40
   • You can check your BMI using the NHS BMI calculator, if you know your height and weight.
   • Your height and weight will also be checked at your appointment, so please provide accurate information.
2. At least four of the following five health conditions must be diagnosed and recorded in your medical history:

• • Hypertension (high blood pressure requiring medication)
  • Obstructive sleep apnoea, confirmed by a sleep clinic
  • Type 2 diabetes
  • Cardiovascular disease (including heart disease, stroke or vascular disease)
  • Hypercholesterolaemia (high cholesterol)

Please do not contact the surgery; if you are eligible to be assessed you will be contacted over the coming months and invited to attend an appointment for assessment. Those with the greatest clinical need will be contacted first.

For further information visit:

Obesity – Treatment – NHS

NHS England » Weight management injections